Cargando…
Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses
Sanfilippo disease (mucopolysaccharidosis type III, MPS III) is a severe metabolic disorder caused by accumulation of heparan sulfate (HS), one of glycosaminoglycans (GAGs), due to a genetic defect resulting in a deficiency of GAG hydrolysis. This disorder is characterized as the most severe neurolo...
Autores principales: | Kloska, Anna, Jakóbkiewicz-Banecka, Joanna, Narajczyk, Magdalena, Banecka-Majkutewicz, Zyta, Węgrzyn, Grzegorz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070076/ https://www.ncbi.nlm.nih.gov/pubmed/21305347 http://dx.doi.org/10.1007/s11011-011-9233-2 |
Ejemplares similares
-
Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway
por: Jakóbkiewicz-Banecka, Joanna, et al.
Publicado: (2009) -
Synthetic genistein derivatives as modulators of glycosaminoglycan storage
por: Kloska, Anna, et al.
Publicado: (2012) -
Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases
por: Jakóbkiewicz-Banecka, Joanna, et al.
Publicado: (2013) -
The model homologue of the partially defective human 5,10-methylenetetrahydrofolate reductase, considered as a risk factor for stroke due to increased homocysteine level, can be protected and reactivated by heat shock proteins
por: Grabowski, Michał, et al.
Publicado: (2016) -
Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids
por: Moskot, Marta, et al.
Publicado: (2015)